An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Oprah Winfrey is spilling the truth about “thin people” after her diet drug journey. Knewz.com can reveal the media mogul, ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

Novo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.

Novo Nordisk's STEP UP trial shows semaglutide 7.2 mg delivers superior weight loss and safety compared to lower doses and ...

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a scientist who developed the revolutionary drugs has said. Professor ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

The move in the stock surprised some experts and analysts ... Guidance for diabetes drug Mounjaro is $3.5 billion, while weight loss drug Zepbound is expected to bring in $1.9 billion for the ...

Tuesday, Five Below (NASDAQ:FIVE) shares, trading at $99.90 and down nearly 5% year-to-date, maintained their Sector Weight rating by ... analysis indicates the stock is currently undervalued ...